Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015, Article ID 279849, 5 pages
http://dx.doi.org/10.1155/2015/279849
Review Article

Interleukin-23R rs7517847 T/G Polymorphism Contributes to the Risk of Crohn’s Disease in Caucasians: A Meta-Analysis

1Liyang People’s Hospital, Liyang 213300, China
2Translational Medicine Research Center of Jiangning Hospital and Liver Transplantation Center of First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China
3Department of Urology, Nanjing First Hospital, Nanjing Medical University, Nanjing 210029, China

Received 27 June 2014; Revised 5 January 2015; Accepted 12 January 2015

Academic Editor: Guixiu Shi

Copyright © 2015 Li Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. M. Malaty, J. K. Hou, and S. Thirumurthi, “Epidemiology of inflammatory bowel disease among an indigent multi-ethnic population in the United States,” Clinical and Experimental Gastroenterology, vol. 3, no. 1, pp. 165–170, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. E. V. Loftus Jr., “Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences,” Gastroenterology, vol. 126, no. 6, pp. 1504–1517, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. J. van Limbergen, D. C. Wilson, and J. Satsangi, “The genetics of Crohn's disease,” Annual Review of Genomics and Human Genetics, vol. 10, pp. 89–116, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Parham, M. Chirica, J. Timans et al., “A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rβ1 and a novel cytokine receptor subunit, IL-23R,” Journal of Immunology, vol. 168, no. 11, pp. 5699–5708, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Aggarwal, N. Ghilardi, M.-H. Xie, F. J. De Sauvage, and A. L. Gurney, “Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17,” The Journal of Biological Chemistry, vol. 278, no. 3, pp. 1910–1914, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. X. Wang, J. Huang, Z. Lin et al., “Single-nucleotide polymorphisms and expression of IL23R in Chinese ankylosing spondylitis patients,” Rheumatology International, vol. 30, no. 7, pp. 955–959, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. R. H. Duerr, K. D. Taylor, S. R. Brant et al., “A genome-wide association study identifies IL23R as an inflammatory bowel disease gene,” Science, vol. 314, no. 5804, pp. 1461–1463, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Faragó, L. Magyari, E. Sáfrány et al., “Functional variants of interleukin-23 receptor gene confer risk for rheumatoid arthritis but not for systemic sclerosis,” Annals of the Rheumatic Diseases, vol. 67, no. 2, pp. 248–250, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Cargill, S. J. Schrodi, M. Chang et al., “A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes,” American Journal of Human Genetics, vol. 80, no. 2, pp. 273–290, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Dong, Q. Li, Y. Zhang, W. Tan, and Z. Jiang, “IL23R gene confers susceptibility to ankylosing spondylitis concomitant with uveitis in a Han Chinese population,” PLoS ONE, vol. 8, no. 6, Article ID e67505, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Wagner, W. H. Sim, J. A. Ellis et al., “Interaction of crohn's disease susceptibility genes in an australian paediatric cohort,” PLoS ONE, vol. 5, no. 11, Article ID e15376, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Zintzaras and J. P. A. Ioannidis, “HEGESMA: genome search meta-analysis and heterogeneity testing,” Bioinformatics, vol. 21, no. 18, pp. 3672–3673, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Safrany, M. Szabo, M. Szell et al., “Difference of interleukin-23 receptor gene haplotype variants in ulcerative colitis compared to Crohn's disease and psoriasis,” Inflammation Research, vol. 62, no. 2, pp. 195–200, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Szabo, E. Safrany, B. Pazar et al., “Marked diversity of IL23R gene haplotype variants in rheumatoid arthritis comparing with Crohn's disease and ankylosing spondylitis,” Molecular Biology Reports, vol. 40, no. 1, pp. 359–363, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. L. R. Ferguson, D. Y. Han, A. G. Fraser, C. Huebner, W. J. Lam, and A. R. Morgan, “IL23R and IL12B SNPs and haplotypes strongly associate with Crohn's disease risk in a New Zealand population,” Gastroenterology Research and Practice, vol. 2010, Article ID 539461, 12 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Lauriola, G. Ugolini, S. Rivetti et al., “IL23R, NOD2/CARD15, ATG16L1 and PHOX2B polymorphisms in a group of patients with Crohn's disease and correlation with sub-phenotypes,” International Journal of Molecular Medicine, vol. 27, no. 3, pp. 469–477, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Lacher, S. Schroepf, J. Helmbrecht et al., “Association of the interleukin-23 receptor gene variant rs11209026 with Crohn's disease in German children,” Acta Paediatrica, vol. 99, no. 5, pp. 727–733, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Latiano, O. Palmieri, M. R. Valvano et al., “Replication of interleukin 23 receptor and autophagy-related 16-like 1 association in adult-and pediatric-onset inflammatory bowel disease in Italy,” World Journal of Gastroenterology, vol. 14, no. 29, pp. 4643–4651, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Márquez, J. L. Mendoza, C. Taxonera et al., “IL23R and IL12B polymorphisms in Spanish IBD patients: no evidence of interaction,” Inflammatory Bowel Diseases, vol. 14, no. 9, pp. 1192–1196, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. M. L. Baptista, H. Amarante, G. Picheth et al., “CARD15 and IL23R influences Crohn's disease susceptibility but not disease phenotype in a Brazilian population,” Inflammatory Bowel Diseases, vol. 14, no. 5, pp. 674–679, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. W. G. Newman, Q. Zhang, X. Liu, C. I. Amos, and K. A. Siminovitch, “Genetic variants in IL-23R and ATG16L1 independently predispose to increased susceptibility to Crohn's disease in a Canadian population,” Journal of Clinical Gastroenterology, vol. 43, no. 5, pp. 444–447, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Okazaki, M. H. Wang, P. Rawsthorne et al., “Contributions of IBD5, IL23R, ATG16L1, and NOD2 to Crohn's disease risk in a population-based case-control study: evidence of gene-gene interactions,” Inflammatory Bowel Diseases, vol. 14, no. 11, pp. 1528–1541, 2008. View at Publisher · View at Google Scholar
  23. J. Oliver, B. Rueda, M. A. López-Nevot, M. Gómez-García, and J. Martín, “Replication of an association between IL23R gene polymorphism with inflammatory bowel disease,” Clinical Gastroenterology and Hepatology, vol. 5, no. 8, pp. 977.e2–981.e2, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. C. A. Anderson, D. C. O. Massey, J. C. Barrett et al., “Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship,” Gastroenterology, vol. 136, no. 2, pp. 523.e3–529.e3, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Zwiers, L. Kraal, T. C. T. M. van de Pouw Kraan, T. Wurdinger, G. Bouma, and G. Kraal, “Cutting edge: a variant of the IL-23R gene associated with inflammatory bowel disease induces loss of microRNA regulation and enhanced protein production,” Journal of Immunology, vol. 188, no. 4, pp. 1573–1577, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Haroon, “Endoplasmic reticulum aminopeptidase 1 and interleukin-23 receptor in ankylosing spondylitis,” Current Rheumatology Reports, vol. 14, no. 5, pp. 383–389, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Sánchez, B. Rueda, J. L. Callejas et al., “Analysis of interleukin-23 receptor (IL23R) gene polymorphisms in systemic lupus erythematosus,” Tissue Antigens, vol. 70, no. 3, pp. 233–237, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. H. Lee, Y. H. Rho, S. J. Choi et al., “The PTPN22 C1858T functional polymorphism and autoimmune diseases—a meta-analysis,” Rheumatology, vol. 46, no. 1, pp. 49–56, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. N. J. Prescott, S. A. Fisher, C. Onnie et al., “A general autoimmunity gene (PTPN22) is not associated with inflammatory bowel disease in a British population,” Tissue Antigens, vol. 66, no. 4, pp. 318–320, 2005. View at Publisher · View at Google Scholar · View at Scopus